ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2700

A Multi-Center Study of the Appropriateness of Anti-Neutrophilic Cytoplasmic Antibody Testing

Tarun S. Sharma1, Vikash Sinha2, Vino Unson2, Saurav Acharya3, Sahar Mohammadi2 and Amer Syed2, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Internal Medicine, Mount.Sinai School of Medicine-Jersey City Medical Center, Jersey City, NJ, 3Internal Medicine, Jersey City Medical Center-Barnabas Health, Jersey City, NJ

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: ANCA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ARHP)

A Multi-Center Study of the Appropriateness of Anti-Neutrophilic Cytoplasmic Antibody Testing

Background/Purpose: Anti Neutrophil Cytoplasmic Antibody (ANCA) test is an Indirect Immunoflorescence test used as an aid in the diagnosis of ANCA Associated Small Vessel Vasculitis (AASVV), namely, Wegener’s Granulomatosis, Churg Strauss Vasculitis and Microscopic Polyangitis and its renal-limited variant (pauci-immune crescentic glomerulonephritis). In an effort to decrease the false positive ANCA tests and improve the clinical utility of this test, guidelines for ANCA testing were proposed in 1999. We aim to compare the trend of ANCA testing in practice with the proposed guidelines and thereby calculate the disparity in testing, if any, including the financial burden such testing would pose.

Methods: In this study, we assembled all the ANCA tests that were ordered on hospitalized patients during a 2 year period at 2 academic medical centers. A chart review (by a physician blinded to ANCA test results) was performed and the indications used by physicians for ordering each of the ANCA tests were then compared against the proposed guideline-indications for ANCA testing.

Results: Of the 204 ANCA tests examined, only 98 were ordered using the guideline indications. The commonest of the non-guideline indications were Colitis(25%) and Liver disease(6%) whereas the commonest guideline indications were Acute Renal Failure(ARF)(54%) and hemoptysis(19%). All 3 positive test results were false positive and failed to meet the guideline indications to begin with. Among the commonest guideline indication of ARF, majority cases(75%) had an alternate obvious etiology for ARF at the time of ordering the ANCA test itself. All the non-guideline testing was ordered by primary care physicians, nephrologists and residents and led to an extraneous health care expenditure of over $25000 for the send-out lab test over the 2 year period.    

Conclusion: In this study we conclude that the ANCA test has limited utility in the academic centers included in our study, mostly due to the use of non-guideline testing indications by physicians. Increased awareness regarding the appropriate use of the ANCA test among physicians is critical since it would not only assist in the diagnosis of AASVV, but also help increase the cost-effectiveness of this crucial test. 

 


Disclosure:

T. S. Sharma,
None;

V. Sinha,
None;

V. Unson,
None;

S. Acharya,
None;

S. Mohammadi,
None;

A. Syed,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-multi-center-study-of-the-appropriateness-of-anti-neutrophilic-cytoplasmic-antibody-testing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology